South Dakota Investment Council Ligand Pharmaceuticals Inc Transaction History

South Dakota Investment Council

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$113.03 - $155.64 $568,088 - $782,246	-5,026 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$99.52 - $215.83 $4,378 - $9,496	44 Added 0.88%	5,026 $766,000
Q4 2019 Feb 11, 2020	SELL	$96.94 - $113.59 $50,214 - $58,839	-518 Reduced 9.42%	4,982 $520,000
Q1 2019 May 03, 2019	BUY	$105.93 - $142.47 $116,523 - $156,717	1,100 Added 25.0%	5,500 $691,000
Q4 2018 Feb 06, 2019	BUY	$128.36 - $272.13 $218,212 - $462,621	1,700 Added 62.96%	4,400 $597,000
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $570,186 - $741,123	2,700 New	2,700 $741,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.89B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.